INMB - Inmune Bio, Inc.

7.14
0.010   0.140%

Share volume: 195,621
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$7.13
0.01
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024 12-31-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Report Date 05-03-2023 08-07-2023 11-01-2023 03-28-2024 05-09-2024 08-01-2024 10-31-2024 03-27-2025
Total revenue 38.000 K 46.000 K 43.000 K 28.000 K 14.000 K 0.000 0.000 0.000
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 38.000 K 46.000 K 43.000 K 28.000 K 14.000 K 0.000 0.000 0.000
    21.05% -6.52% -34.88% -50.00% -100.00% nan% nan%  
Operating expenses 6.461 M 6.457 M 8.571 M 8.407 M 11.031 M 9.865 M 12.286 M 9.467 M
Selling general and admin 2.328 M 2.309 M 2.586 M 2.400 M 2.338 M 2.812 M 2.219 M 2.114 M
Research and development 4.133 M 4.148 M 5.985 M 6.007 M 8.693 M 7.053 M 10.067 M 7.353 M
Total expenses 6.461 M 6.457 M 8.571 M 8.407 M 11.039 M 9.865 M 12.286 M 9.459 M
    -0.06% 32.74% -1.91% 31.31% -10.64% 24.54% -23.01%  
Operating income -6.423 M -6.411 M -8.528 M -8.379 M -11.017 M -9.865 M -12.286 M -9.467 M
Ebit -6.423 M -6.411 M -8.528 M -8.379 M -11.017 M -9.746 M -12.286 M -9.467 M
Pretax income -6.536 M -6.501 M -8.563 M -8.408 M -11.017 M -9.746 M -12.093 M -9.226 M
    -0.54% 31.72% -1.81% 31.03% -11.54% 24.08% -23.71%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -6.536 M -6.501 M -8.563 M -8.408 M 0.000 0.000 0.000 0.000
    0.54% -31.72% 1.81% 100.00%        
Net income -6.536 M -6.501 M -8.563 M -8.408 M -11.025 M -9.746 M -12.093 M -9.218 M
    0.54% -31.72% 1.81% -31.13% 11.60% -24.08% 23.77%